Ensuring safety and maintaining business continuity during an infectious disease outbreak
First written in FY2020. 4 of 6 entries say "Restated". Latest entry: FY2022-Q2.
24 other companies' latest entry also says "Restated".
- FY2022-Q2RestatedAnnual report
「Regarding the impact of COVID-19, the company continues its business activities under stringent infection-control measures and maintains utilization at the same level as under normal conditions. In addition, as customers have once again sought to avoid the three Cs, the convenience of home-delivered medicines has been reassessed and demand has increased.」
The company continues to state that it will maintain operations while implementing infection-control measures and leverage the convenience of home-delivered medicines. - FY2022-Q1RestatedAnnual report
「During the COVID-19 pandemic, we have continued our business activities with stringent measures in place and are currently maintaining an operating rate at the same level as in normal times. Customers once again reassessed the convenience of home-delivered medicines and their need for them increased as they sought to avoid the "3 Cs."」
The company continues to state that it will maintain operations while implementing infection-control measures and keep utilization at the same level as under normal conditions. - FY2021-Q3RestatedAnnual report
「During the COVID-19 pandemic, we have continued our business activities with stringent measures in place and are currently maintaining an operating rate at the same level as in normal times. Customers once again recognized the convenience of home-delivered medicines and their need for them increased as they sought to avoid the "3 Cs." Accordingly, our sales representatives made regular visits and delivered products meeting customers' diverse needs, ranging from health-related products to daily necessities and food.」
We have maintained an operating rate at the same level as in normal times while implementing infectious-disease control measures, and continue regular visits and product deliveries through home-delivered medicines. - FY2021-Q2RestatedAnnual report
「During the COVID-19 pandemic, we have continued our business activities with stringent measures in place and are currently maintaining an operating rate at the same level as in normal times. Customers once again reassessed the convenience of home-delivered medicines and their need for them increased as they sought to avoid the "3 Cs." Accordingly, our sales representatives made regular visits and delivered products meeting customers' diverse needs, ranging from health-related products to daily necessities and food.」
We continue our business activities while implementing infectious-disease control measures, using the convenience of home-delivered medicines to make regular visits and deliver products ranging from health-related products to daily necessities and food. - FY2021-Q1AdvancedAnnual report
「Customers once again reassessed the convenience of home-delivered medicines and their need for them increased as they sought to avoid the "3 Cs." Accordingly, our sales representatives made regular visits and delivered products meeting customers' diverse needs, ranging from health-related products to daily necessities and food.」
During the infectious disease outbreak, we used the convenience of home-delivered medicines and made regular visits to deliver daily necessities and food in addition to health-related products. - FY2020First statedAnnual report
「During the COVID-19 pandemic, we have continued our business activities with stringent measures in place and are currently maintaining an operating rate at the same level as in normal times.」
We have stated that we will prioritize customer and employee safety, continue business activities while implementing stringent measures, and maintain an operating rate at the same level as in normal times.